Venture Fund Targets Data-Driven Health Technologies | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Venture Fund Targets Data-Driven Health Technologies

March 19, 2017
by David Raths
| Reprints
Seattle-based Biomatics to invest in 15 to 20 startups

Seattle-based Biomatics Capital Partners, a venture capital firm focused on genomics, digital health and data-driven healthcare technologies, has announced the closing of its initial fund of $200 million, in excess of its target of $150 million.

Biomatics focuses on advancing academic research and early-stage health care innovation to commercialization. The firm estimates that it will invest in 15 to 20 companies through this fund, acting as Series A lead investor in a majority of the deals. Initial investments typically range from $5 million to $10 million, with up to $20 million over the life of the investment.

Leading its team are managing directors Boris Nikolic, M.D., and Julie Sunderland, who have invested together in emerging technology, healthcare and life science ventures since 2010. Once they have invested, they take an active role with portfolio companies, supporting startups with hiring, intellectual property, regulatory issues and exit strategy.  

In a prepared statement, Nikolic, who previously served as chief advisor for science and technology to Bill Gates, said the healthcare ecosystem is at a tipping point. "In the next decade, breakthrough science and technology will fundamentally transform the practice of medicine and delivery of healthcare. Data will drive this transformation."

Prior to co-founding Biomatics with Dr. Nikolic in 2016, Sunderland was director of Program Related Investments for the Bill & Melinda Gates Foundation. "By combining the best of science with sound investment practices, we are looking to create extraordinary financial value for our investors and a pathway to better patient outcomes,” she said in a statement.  

Biomatics' current portfolio includes: 

• AiCure (medication adherence powered by artificial intelligence)

• Aledade (data-driven business model for accountable health care) 

• BlackThorn Therapeutics (informatics-driven drug discovery) 

• Blue Talon (enterprise-level data security for health care) 

• Denali Therapeutics (next-gen therapeutics for neurodegenerative diseases)

• GRAIL (genomics-based cancer screening)

• Omniome (low-cost DNA sequencing platform)

• Twist Bioscience (synthetic DNA)

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

HIT Advisory Committee Advances Recommendations on Core Data Sets for Interoperability

The Health Information Technology Advisory Committee, a federal advisory committee to the Office of the National Coordinator for Health IT (ONC), voted Wednesday to approve nine recommendations to update the list of data elements that vendors must exchange to be considered interoperable.

ACP Study: Only 37 Percent of MIPS Measures Are Valid

A new study from the American College of Physicians Performance Measurement Committee rated as valid only 37 percent of the 86 Quality Payment Program measures for 2017 deemed relevant to ambulatory general internal medicine.

Intermountain Healthcare Launches Study to Unlock Genomic Data

Researchers from the Salt Lake City, Utah-based Intermountain Healthcare have announced a long-term prospective study that they think has the potential to help physicians and others unlock genomic data.

UNC Health Care Receives HIMSS Analytics Stage 7 Designation

UNC Health Care, an integrated health care system based in Chapel Hill, N.C., has achieved Stage 7 designation on the HIMSS Analytics’ Electronic Medical Record Adoption Model (EMRAM).

FDA Announces Plan to Advance Medical Device Safety and Cybersecurity

The Food and Drug Administration (FDA) has announced new proposals aimed at advancing medical device cybersecurity, including placing new responsibilities on manufacturers, both before and after their devices hit the market.

Black Book: 9 in 10 Small Practices Not Optimizing Advanced EHR Functionalities

Eighty-eight percent of small practices of six or less practitioners still aren't optimizing advanced EHR (electronic health record) tools such as patient engagement, secure messaging, decision support and electronic data sharing, according to the latest Black Book survey